Fig. 1From: Evaluation of the tolerability and safety of [225Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation studyDose-escalation design of the 225Ac-PSMA I&T phase I trial. DL = Dose Level. MBq = MegabecquerelBack to article page